We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AMAG Pharmaceuticals Inc | NASDAQ:AMAG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.75 | 13.04 | 13.90 | 0 | 01:00:00 |
001-10865
|
|
04-2742593
|
(Commission File
Number)
|
|
(IRS Employer Identification
No.)
|
1100 Winter St.
|
|
|
Waltham, Massachusetts
|
|
02451
|
(Address of principal executive
offices)
|
|
(Zip Code)
|
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release entitled “AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update” issued by AMAG Pharmaceuticals, Inc. on August 3, 2017.
|
99.2
|
|
Copy of AMAG Pharmaceuticals, Inc.’s presentation slides dated August 3, 2017.
|
|
AMAG PHARMACEUTICALS, INC.
|
|
|
By:
|
/s/ Joseph D. Vittiglio
|
|
|
Joseph D. Vittiglio
General Counsel, Senior Vice President of Legal Affairs, Technical Operations and Quality and Secretary
|
|
|
|
|
Date: August 3, 2017
|
Exhibit
Number
|
Description
|
|
99.1
|
|
Press release entitled “AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update” issued by AMAG Pharmaceuticals, Inc. on August 3, 2017.
|
99.2
|
|
Copy of AMAG Pharmaceuticals, Inc.’s presentation slides dated August 3, 2017.
|
1 Year AMAG Pharmaceuticals Chart |
1 Month AMAG Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions